Will tylenol fool your glucose monitor? new study investigates

NCT ID NCT06560177

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether taking acetaminophen (like Tylenol) interferes with a new continuous glucose monitor called Biolinq. Thirty-one adults with diabetes wore the Biolinq sensor and a standard CGM for three days. On day three, they took acetaminophen and researchers compared the sensor's readings to lab blood tests to see if the drug caused errors.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Biolinq MicroArray Intradermal Continuous Glucose Biowearable System (a device)
What this could lead to
If successful, this study could confirm that the Biolinq sensor works accurately even when users take acetaminophen, a common pain reliever.
What could go wrong
This is a small, early-stage study with only 31 participants and a single day of testing. Results may not apply to all people or real-world conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Rocky Mountain Clinical Research

    Idaho Falls, Idaho, 83404, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.